Pfizer says COVID-19 vaccine shows 90.7% efficacy in trial in children October 22, 2021 by Toronto Sun NEW YORK — The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday. Read More